Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4276 AL 4290

Reduction of Oxidative/Nitrosative Stress in Brain and its Involvement in the Neuroprotective Effect of n-3 PUFA in Alzheimer's Disease

Serini S, Calviello G.

Curr Alzheimer Res. 2016;13(2):123-34. doi: 10.2174/1567205012666150921101147.

Withanolides: Biologically Active Constituents in the Treatment of Alzheimer's Disease

Khan SA, Khan SB, Shah Z, Asiri AM.

Med Chem. 2016;12(3):238-56. doi: 10.2174/1573406411666151030112314.

Memantine and Kynurenic Acid: Current Neuropharmacological Aspects

Majláth Z, Török N, Toldi J, Vécsei L.

Curr Neuropharmacol. 2016;14(2):200-9. doi: 10.2174/1570159x14666151113123221.

Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease

Novak G, Fox N, Clegg S, Nielsen C, Einstein S, Lu Y, Tudor IC, Gregg K, Di J, Collins P, Wyman BT, Yuen E, Grundman M, Brashear HR, Liu E.

J Alzheimers Dis. 2016;49(4):1123-34. doi: 10.3233/JAD-150448.

Intracellular and extracellular microtubule associated protein tau as a therapeutic target in Alzheimer disease and other tauopathies

Avila J, Pallas N, Bolós M, Sayas CL, Hernandez F.

Expert Opin Ther Targets. 2016 Jun;20(6):653-61. doi: 10.1517/14728222.2016.1131269. Epub 2016 Feb 16.

Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease

Bu XL, Jiao SS, Lian Y, Wang YJ.

Curr Alzheimer Res. 2016;13(3):307-16. doi: 10.2174/1567205013666151215110114.

Home Modifications for People With Alzheimer's Disease: A Scoping Review

Struckmeyer LR, Pickens ND.

Am J Occup Ther. 2016 Jan-Feb;70(1):7001270020p1-9. doi: 10.5014/ajot.2015.016089.

[Pharmacotherapy and dementia]

Drobizhev MY, Fedotova AV, Kikta SV, Antokhin EY.

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(10):110-116. doi: 10.17116/jnevro2016116101110-116.

Medicinal Chemistry Focusing on Aggregation of Amyloid-β

Sohma Y.

Chem Pharm Bull (Tokyo). 2016;64(1):1-7. doi: 10.1248/cpb.c15-00742.

Relearning of Activities of Daily Living: A Comparison of the Effectiveness of Three Learning Methods in Patients with Dementia of the Alzheimer Type

Bourgeois J, Laye M, Lemaire J, Leone E, Deudon A, Darmon N, Giaume C, Lafont V, Brinck-Jensen S, Dechamps A, König A, Robert P.

J Nutr Health Aging. 2016 Jan;20(1):48-55. doi: 10.1007/s12603-016-0675-4.

Tau Biology and Tau-Directed Therapies for Alzheimer's Disease

Bakota L, Brandt R.

Drugs. 2016 Mar;76(3):301-13. doi: 10.1007/s40265-015-0529-0.

Impact of functional alterations on quality of life in patients with Alzheimer's disease

Barbe C, Morrone I, Wolak-Thierry A, Dramé M, Jolly D, Novella JL, Mahmoudi R.

Aging Ment Health. 2017 May;21(5):571-576. doi: 10.1080/13607863.2015.1132674. Epub 2016 Jan 8.

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies

Šimić G, Babić Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milošević N, Bažadona D, Buée L, de Silva R, Di Giovanni G, Wischik C, Hof PR.

Biomolecules. 2016 Jan 6;6(1):6. doi: 10.3390/biom6010006.

The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer's disease: Acting separately or synergistically?

Song C, Shieh CH, Wu YS, Kalueff A, Gaikwad S, Su KP.

Prog Lipid Res. 2016 Apr;62:41-54. doi: 10.1016/j.plipres.2015.12.003. Epub 2016 Jan 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias